Cannabidiol, Essential Oils, and CAMs - NPANA · Cannabidiol, Essential Oils, and CAMs Tracy L....
Transcript of Cannabidiol, Essential Oils, and CAMs - NPANA · Cannabidiol, Essential Oils, and CAMs Tracy L....
Cannabidiol, Essential Oils, and CAMs
Tracy L. Skaer, PharmD, FASHP, FASCP
Professor Emeritus of Pharmacotherapy
Nicole Perea, PharmD
Academic Fellow in Pharmacotherapy
Disclosure
We have no actual or potential conflict of
interest in relation to this program /
presentation.
2
Objectives
Describe the potential
uses, benefits, and
safety concerns related
to the use of
cannabidiol (CBD) and
essential oils for the
treatment of pain
Identify other CAMS
that may be beneficial
for the treatment of
post-op pain to help
minimize reliance on
opioid
pharmacotherapy.
Cannabinoids Background
Cannabis plant 100+ different
cannabinoids
Primary active compounds: CBD and
THC
CBD: non-psychoactive; THC –
psychoactive
Hemp: seeds, stems, non-flower parts
of cannabis plant made into rope or
clothing; for sale online.
Hemp is mostly CBD and can contain
no more than 0.3% THC.
Image Source: Natural
Center for Complementary
and Integrative Health
Controlled Substances Act (CSA) Exempts sterilized seeds, fiber, and stalk from
definition of marijuana as a Schedule I drug
Contains no standardized definitions for “medical
marijuana”, “high-CBD,” or “low-THC”; no
regulation among products
State laws on medical marijuana and cannabis
products vary
CBD Versus THC
Anti-nauseant
Appetite Stimulant
Analgesic
Muscle spasms
Causes: euphoria,
drowsiness, mood
changes, impaired
memory, changes in
cognition and problem
solving, dependence,
addiction
Anti-inflammatory
Analgesic
Neuroprotective
Antiepileptic
Anti-nauseant
Anxiolytic
No Euphoria: suppresses
psychoactive effects of
THC
Causes: drowsiness,
lethargy
Cannabinoids in Pain (some examples)
Research available on opioid sparing effects of
cannabinoids (primarily delta-9-THC +/- CBD)
Nielsen et al effective opioid dose 3.6 times lower
in animals subjects with concomitant THC.
Mondello et al THC/CBD remarkable analgesic
capabilities as adjuvants to spinal cord stimulation for
refractory failed back surgery syndrome (FBSS)
refractory pain
Cannabinoids – Nausea and Vomiting
Effectiveness of cannabinoids reducing nausea and
vomiting in chemotherapy patients is widely known
Hypothesis: surgical patients at high risk for PONV
may also benefit
Only limited research available for cannabinoids in
PONV; no demonstrated efficacy for THC, nabilone
(synthetic cannabinoid)
No research available for CBD in PONV
Key: PONV – post-op nausea and vomiting
CBD Dietary Supplements
FDA warning letters sent to several CBD
supplement manufacturers
Misbranded products – false claims,
ingredients not what’s on the label
Website claims are for drugs
Foods may not contain approved drugs
FDA excluding CBD products as dietary
supplements
Ongoing CBD research and approval of
Epidiolex® indicated new drug application
Cannabidiol (Epidiolex®) Highly purified pharmaceutical grade CBD
FDA approval (June 25, 2018) for Lenox-Gastaut
Syndrome (LGS) and Dravet syndrome
Orphan Drug designation: autoimmune hepatitis,
prevention of ischemia/reperfusion injury from solid
organ transplantation
Schedule V controlled substance (verses Schedule I
for THC)
Cannabidiol (Epidiolex®) MOA
Does NOT bind to CB receptors
Antagonizes CB1 and CB2 receptor agonists (i.e. THC)
Also, non-competitive negative allosteric modulator of
CB1 and CB2
Agonist of vanilloid / capsaicin receptor TRPV1 body
temperature, heat sensation, pain nociception
Facilitate neurotransmission by serotonin receptor 5-
HT1a mood, anxiety, aggression
Activates peroxisome proliferator-activated receptor Y
(PPARy) anti-inflammatory, glucose and lipid storage
Cannabidiol (Epidiolex®) MOA (cont.)
Antagonizes G-protein-coupled receptor GPR55, GPR2,
GPR6, GPR12 Parkinson’s, Huntington’s
Increases mitochondrial complexes (rodents)
neuroprotection, Parkinson’s
Decreases pro-inflammatory cytokines IL-1β, TNF-α, IFN-β,
IFN-γ, IL-17, and IL-6
Increases anti-inflammatory cytokines IL-4 and IL-10
Inhibits COX2 anti-inflammatory
Antioxidant / free radical scavenging properties
Anticonvulsant effect – MOA unknown
Cannabidiol (Epidiolex®) ADRs > 5%
Somnolence (23-25%)
Fatigue/malaise (12%)
Sedation (3-6%)
Sleep quality / insomnia
(4-11%)
Lethargy (4-8%)
Irritability (5-9%)
Reduced Appetite
(16-22%)
Diarrhea (9-20%)
Rash (7-13%)
ALT and/or AST
elevations (8-16%)
Cannabidiol (Epidiolex®) Precautions
Pregnancy – birth defects
and miscarriage risk
unknown. Enroll all PG
mothers in North American
Antiepileptic Drug (NAAED)
Pregnancy Registry
Breastfeeding – infant risk
cannot be ruled out
Providers should evaluate
risk/benefit
• Monitor for changes in
behavior or mood,
aggression, suicidal
thoughts / behaviors
• Do not abruptly
withdrawal
Cannabidiol (Epidiolex®) Warnings
Potential for positive result on cannabis drug
screen. Random drug testing concerns
Monitor for hepatocellular injury at 1, 3, and 6
months post-initiation. More frequent if taking
valproate or elevated LFTs at baseline
Dose-related elevations in AST, ALT, total Bili:
Increase risk: valproate, clobazam, or medications
known to increase LFTs.
Cannabidiol Interactions – Moderate Risk
CNS depressants
CYP3A4 and
CYP2B6
CYP1A2 and
CYP1A9
CYP2B6CYP2C9
and CYP2C19
UGT1A9 and
UGT2B7
Cannabidiol Interaction Examples
CYP3A4 Moderate Inhibitors: amiodarone,
erythromycin, fluconazole, miconaole, diltiazem,
verapamil, delavirdine, amprenavir, fosamprenavir,
conivaptan
CYP3A4 Strong Inhibitors: clarithromycin,
telithromycin, nefazodone, itraconazole, grapefruit
juice, ketoconazole, atazanavir, darunavir, indinavir,
ritonavir, saquinavir, tipranivir
Cannabidiol Interaction Examples
CYP 2C19 Moderate Inhibitors: esmeprazole,
fluoxetine, moclobemide, omeprazole, voriconazole
CYP2C19 Strong Inhibitor: Amitriptyline,
clomipramine, fluconazole, fluvoxamine,
imipramine, ticlopidine
For complete list of medications affecting CYP see:
FDA list
Cannabidiol – Surgical Considerations
Bleeding risk – theoretically may interfere with
warfarin metabolism at CYP1A2 and CYP3A4
Pain control – adjunctive role perhaps, more research
is needed
Enhanced sedation – combination with CNS
depressants including opioids.
Safety – large margin of safety, well tolerated, drug
interaction concerns
Supplements vs Rx – quality issues
Essential OilsImage Source: WebMD
About Essential Oils• A mixture of saturated and unsaturated hydrocarbons,
alcohols, aldehydes, esters, ethers, oxides, phenols, and
terpenes that produce characteristic odors
• Used by ancient civilizations over 6,000 years ago
• Florence Nightingale used lavender oil on soldiers and
proclaimed that nursing care should put the patient in the
best condition for nature’s reparative processes to work
• Administered by: inhalation, massage, or topically (at
pulse points to enhance absorption or via Vita Flex)
EOs Pharmacophysiological MOA
EO inhaled
through the nose
Nasal receptors integrate
into biological signal
Signal transmitted to limbic
system via olfactory bulb
Endorphins, serotonin, and
norepinephrine released
Eos Pschophysioloical MOA• Pleasant aroma altered
psychological state
emotional distraction-like
response
• Psychological or emotional
alteration may be indirectly
related to limbic system via the
amygdala, thalamus, and
hypothalamus responsible for
emotional reactivity
Image Source: https://www.news-
medical.net/health/Limbic-System-and-Behavior.aspx
Essential Oils Vita Flex Technique
• Vita Flex – vitality through the reflexes
• Applying EOs topically using specialized form of hand
and foot massage
• EOs applied on reflexology points on hands and feet
or on affective area
• Technique – apply oil to area or on finger pads;
roll/rotate finger pads over until finger nail is touching
the skin, move to next position and repeat.
Essential Oils Aromatherapy
• Applied topically or through inhalation
• Inhalation is fastest onset
• Low cost, minimal side effects, generally safe (FDA)
• Many claims but most research focuses on depression,
anxiety, muscle tension, sleep disturbance, nausea,
and pain.
• More effective at treating nociceptive and acute pain
inflammatory and chronic pain
EOs for PainEucalyptus
Image sources:
organic facts.net
Lavender Lemon Clary Sage
Marjoram Peppermint Rose
Ginger Spearmint Cardamom
Lavender EOs for PONV
Aromatotherapy with ginger; combination of
ginger, spearmint, peppermint, and cardamom;
QueaseEase® (lavender, peppermint, ginger,
spearmint) all found effective for PONV.
EOs Adverse Effects• Hypersensitivity
• Rash, contact dermatitis, and skin
irritations (burns, hives, blistering)
• Photosensitivity
• Respiratory reactivity
• Mucous membrane irritation
• Nausea, vomiting
• Seizures (oral eucalyptus)
• Gynecomastia in prepubescent boys
(lavender and tea tree oil)
Image Source: WebMD
Consumer overuse is
a major concern.
EOs Research Limitations and Concerns
• Difficult to deceive patients with placebo oils; patient’s
aware of their assigned groups
• Duration of EO interventions varied across trials
• Lack of standardized treatment procedure in each study
• Multiple delivery methods, differing blends of EOs and
herbs, non-standardized doses poor reproducibility
• Many recent trials primarily from Iran - Possible
publication bias and lack of registration and retrospective
registration threaten validity
Dietary Supplements and Surgery
Discontinue 2 weeks prior to surgery
Coagulation/bleeding: Ginko, Ginger, Garlic, Ginseng,
Green Tea, Vitamin E, Gucosamine, Chondroitin, Devil’s
claw, Willow bark, Dong quai, Feverfew, Fish oil, DHEA, Co
Q-10, Fenugreek, Evening primrose oil,
Enhances anesthesia: Kava, St. John’s wort, Valerian,
Nelatonin, Lemon balm
CV risk (HR and/or BP): Ephedra (ma huang), Garlic
Reducing Reliance on Opioids
Psychotherapy
Acupuncture
Massage +/- EOs
Chiropractic
Exercise
PT/OT
Reflexology +/- EOs
Mindbody - mindfulness, yoga,
meditation, Tai Chi, Qigong
Biofeedback
Stress management
Psychotherapy
Antidepressants
Neuroleptics
Sleep Hygiene
Foot Reflexology
Image Source: Pacific College
of Oriental Medicine
Hand Reflexology
Image Source:
Ma’ati Spa
Acupuncture
Massage Therapy• Soft tissue manipulation has been practiced for thousands
of years.
• Common goal: help the body heal itself
36
Mindfulness
“The awareness that emerges through paying attention on purpose, in the present moment, and non-judgmentally to the unfolding experience moment by moment.”- Jon Kabat-Zinn, Ph.D. 1994
Intension
AttentionAttitude
NOW
37
Practice Foundations: 7 Core Attitudes
1. Non-judging
2. Beginner’s mind
3. Patience
4. Trust
5. Non-striving
6. Acceptance
7. Letting go/be; non-attachment
38
Mindfulness Practices
FORMAL
Meditation (e.g. body scan,
sitting, walking, cultivating
kindness, embracing the
unwanted, awareness of
breath)
Mindful movement (e.g.
yoga, gentle stretches)
INFORMAL
Awareness of body
sensations, thoughts,
emotions in everyday life
Mindful activities of daily
living (e.g. eating,
showering, vacuuming,
brushing teeth)
The Guest House
40
This being human is a guest house. Every morning a new
arrival.
A joy, a depression, a meanness, some momentary
awareness comes as an unexpected visitor.
Welcome and entertain them all! Even if they are a crowd of
sorrows, who violently sweep your house empty of its
furniture, still, treat each guest honorably. He may be
clearing you out for some new delight.
The dark thought, the shame, the malice, meet them at the
door laughing, and invite them in.
Be grateful for whoever comes, because each has been
sent as a guide from beyond.
- Jalal al-Din Rumi
Mindfulness Uses
Stress management
Depression
Anxiety disorders
PTSD
Insomnia
Chronic Pain
Substance abuse,
addictions
Personality disorders
Disordered eating
Parenting skills
Traumatic Brain Injury
ADHD and Autism
Parkinson’s Disease
….more to come
41
Mindfulness Reduces Stress by:
• Enhances awareness of thoughts reduces
negative response styles (rumination,
pessimism)
• Reduces emotional reactivity – “wise mind”
• Present moment mindset
• Improves awareness and sensitivity to
mind/body
42
Mindfulness Reduces Stress by:
• Increases awareness of emotions of others
creating empathy and reduced conflict
• Promotes self-care and self-compassion
• Reduces the fear response and threat
detection
• Enhances cognition and concentration
• Changes attitudes about stressors
positive thinking towards addressing
stress
43
Benefits of Mindfulness Practices
• Improved attention
• Reduced ruminative thinking
• Diminished emotional reactivity
• Enhanced self-awareness, -expression, -acceptance
• Improved coping
• Reduced blood pressure
• Changes in pain perception and coping
• Possible improved immune function
• Possible reduced cortisol levels
• Possible enhanced cognition
44
“Lost”
Stand still.. The trees ahead and bushes beside you
Are not lost. Wherever you are is called Here,
And you must treat it as a powerful stranger,
Must ask permission to know it and be known.
The forest breathes. Listen. It answers,
I have made this place around you.
If you leave it, you may come back again, saying Here.
No two trees are the same to Raven.
No two branches are the same to Wren.
If what a tree of a bush does is lost on you,
You are surely lost. Stand still. The forest knows
Where you are. You must let it find you.
-David Wagoner
Summary Highly purified form of CBD (C-V) is now available via Rx
approved for treatment of Lenox-Gastaut Syndrome (LGS)
and Dravet syndrome.
Recreational CBD supplements are not pharmaceutical
grade and may be misbanded.
CBD is highly metabolize by liver and subject to multiple
interactions.
THC +/- CBD demonstrated opioid sparing effects.
No research available for CBD in PONV.
Screen dietary supplements prior to surgery to avoid ADRs.
Summary• Multiple EOs found efficacious as adjuvants for the
treatment of pain and PONV.
• CAMs such as acupuncture, mindfulness, meditation,
chiropractic, massage, reflexology, and movement therapies
(e.g., yoga, Tai Chi, Gigong) may be useful in reducing
opioid demands.
• Consider alternative medications for chronic pain such as
antiepileptics and antidepressants.
• Psychotherapy for all chronic pain patients.
• Teach all patients proper sleep hygiene.
• Get patients involved in own self-care.
QUESTIONS
References
1. Mondello E, et al. Cannabinoids and spinal cord
stimulation for the treatment of failed back surgery
syndrome refractory pain. J Pain Res 2018;11:1761-7.
2. Nielsen S, et al. Opioid-sparing effect of cannabinoids:
A systematic review and meta-analysis.
Neuropscyhopharmacol 2017;42:1752-65.
3. Bakshi C, Barrett AM. Impact of recreational and
medicinal marijuana on surgical patients: a review. Am
J Surg 2018; in press.
4. Cannabidiol Drugdex evaluation. IBM Micromedex.
Last modified: November 27, 201849
References
5. Peres FF, et al. Cannabidiol as a promising strategy to
treat and prevent movement disorders. Front
Pharmacology. 2018 May 11:8:482. doi:
10.3389/fphar.2018.00482. eCollection 2018.
6. Kleine-Brueggency, et al. IV deta-9THC to prevent
postoperative nausea and vomiting: A randomized
controlled trial. Anesth Analg 2015;121(5):1157-64.
7. Leven DN, et al. A randomized-controlled trial of
nabilone for the prevention of acute postoperative
nausea and vomiting in elective surgery. Can J
Anesth/J Canadien Danesthesie 2017;64(4):385-95.50
References8. Cannabinoids and drug interactions. Drug Consult, IBM
Micromedex. Last modified: October 3, 2018.
9. Richtig G, et al. Cannabis consumption before surgery
may be associated with increased tolerance of anesthetic
drugs: a case report. Int J Case Rep Images
2015;6(7):436-9.
10.Welliver MD. Essential oils: an adjunct to holistic
nursing. Gasteroent Nurs 2018;41(3):250-4.
11.Marin GN. The effect of exposure to odor on the
perception of pain. Psychosom Med 2006;68:613-6
51
References12.Lakhan SE, et al. The effectiveness of aromatherapy in
reducing pain: a systematic review and meta-analysis.
Pain Res Treatment 2016;
http://dx.doi.org/10.1155/2016/8158693
13.Lee MS, et al. Aromatherapy for managing pain in
primary dysmenorrhea: a systematic review of
randomized placebo-controlled trials. J Clin Med
2018;7:434.
14.Marshall L. Essential Oils: Natural doesn’t mean risk-
free. WebMD 2017. https://www.webmd.com/skin-
problems-and-treatments/news/20170809/essential-
oils-natural-doesnt-mean-risk-free52